AD-26-SL71_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 6-(2,2-Diphenylethylamino)-9-[(2r,3r,4s,5s)-5-(Ethylcarbamoyl)-3,4-Dihydroxy-Oxolan-2-Yl]-N-[2-[(1-Pyridin-2-Ylpiperidin-4-Yl)carbamoylamino]ethyl]purine-2-Carboxamide, Adenosine A2A Agonists targeting ADORA2A (Novartis, 9833519)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/9833519
Similar Terms
Downloads & Tools

Genes

14 genes differentially expressed following the AD-26-SL71_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPLP2 ribosomal protein, large, P2 0.313568
PSMB6 proteasome (prosome, macropain) subunit, beta type, 6 0.299397
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.263392
BDKRB1 bradykinin receptor B1 0.263392
SSR4 signal sequence receptor, delta 0.252209
LGALS1 lectin, galactoside-binding, soluble, 1 0.250613
EGR2 early growth response 2 0.247616
NDUFB10 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa 0.247616
RPS14 ribosomal protein S14 0.24284
NDUFA11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa 0.242839

decreased expression

Symbol Name Standardized Value
FBH1 F-box DNA helicase 1 -0.377041
ZMPSTE24 zinc metallopeptidase STE24 -0.224509
GRIPAP1 GRIP1 associated protein 1 -0.220291
ARF6 ADP-ribosylation factor 6 -0.215872